Penn Medicine Researchers Receive $7.5 Million to Expand HIV Gene Therapy Work
Penn Medicine Researchers Receive $7.5 Million to Expand HIV Gene Therapy Work
Researchers from the Perelman School of Medicine and the Penn Center for AIDS Research (CFAR) have been awarded $7.5 million over five years from the National Institutes of Health to initiate a multi-project HIV study investigating a new gene therapy approach to render immune cells of HIV positive patients resistant to the virus.